Skip to main content

Table 4 Concentrations of anti-Hsp60 and anti-Hsp65 IgG antibodies in group of women with ovarian cancer depending on histopathological type of tumor and in control group

From: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer

  Ovarian cancer Controls
Adenocarcinoma papillare serosum Adenocarcinoma mucinosum Adenocarcinoma endometrioides n = 80
n = 82 n = 44 n = 23
Anti-Hsp60 (AU/ml) 104,17 ± 159,89 82,94 ± 82,87 77,77 ± 83,41 62,42 ± 33,93
(mean ± SD)
  % of positive results 26%* 19% 21% 10%
  (> 90 percentile for control group) p = 0.0075 p = 0.1476 p = 0.1535
Anti-Hsp65 (AU/ml) 106,41 ± 217,07 78,64 ± 85,73 85,32 ± 92,47 56,35 ± 35,57
(mean ± SD)
  % of positive results 21,5%* 15% 29%* 10%
  (> 90 percentile for control group) p = 0.0424 p = 0.3972 p = 0.0200
  1. *p < 0.05 in group of women with ovarian cancer compared to control group.